Crosstalk between Entamoeba histolytica and the human intestinal tract during amoebiasis.


Journal

Parasitology
ISSN: 1469-8161
Titre abrégé: Parasitology
Pays: England
ID NLM: 0401121

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 8 12 2017
medline: 10 5 2020
entrez: 8 12 2017
Statut: ppublish

Résumé

The protozoan parasite Entamoeba histolytica is the microbial agent of amoebiasis - an infection that is endemic worldwide and is associated with high morbidity and mortality rates. As the disease develops, virulent E. histolytica deplete the mucus layer, interact with the intestinal epithelium, and then degrade the colonic mucosa and disrupt the extracellular matrix (ECM). Our research demonstrated that virulent parasites with an invasive phenotype display rapid, highly specific changes in their transcriptome (notably for essential factors involved in carbohydrate metabolism and the processing of glycosylated residues). Moreover, combined activation of parasite and host lytic enzymes leads to the destruction of the intestinal parenchyma. Together, these enzymes degrade the mucus layer and the ECM, and trigger the inflammatory response essential to the development of amoebiasis.

Identifiants

pubmed: 29212561
pii: S0031182017002190
doi: 10.1017/S0031182017002190
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1140-1149

Auteurs

Elisabeth Labruyère (E)

Bioimage Analysis Unit,Institut Pasteur,Paris,France.

Roman Thibeaux (R)

Cell Biology of Parasitism Unit,Institut Pasteur,Paris,France.

Jean-Christophe Olivo-Marin (JC)

Bioimage Analysis Unit,Institut Pasteur,Paris,France.

Nancy Guillén (N)

Cell Biology of Parasitism Unit,Institut Pasteur,Paris,France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH